Carson Wealth (CWM LLC)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.02M | Buy |
159,652
+73,036
| +84% | +$4.26M | 0.02% | 588 |
|
|
2025
Q4 | $5.15M | Sell |
86,616
-77,791
| -47% | -$4.24M | 0.01% | 760 |
|
|
2025
Q3 | $8.9M | Buy |
164,407
+76,452
| +87% | +$4.37M | 0.03% | 509 |
|
|
2025
Q2 | $4.83M | Buy |
87,955
+27,894
| +46% | +$1.64M | 0.02% | 597 |
|
|
2025
Q1 | $4.25M | Buy |
60,061
+33,746
| +128% | +$2.27M | 0.02% | 575 |
|
|
2024
Q4 | $1.73M | Buy |
26,315
+15,209
| +137% | +$1.02M | 0.01% | 840 |
|
|
2024
Q3 | $781K | Buy |
11,106
+8,708
| +363% | +$728K | ﹤0.01% | 1155 |
|
|
2024
Q2 | $197K | Buy |
2,398
+975
| +69% | +$81.2K | ﹤0.01% | 1593 |
|
|
2024
Q1 | $124K | Sell |
1,423
-42
| -3% | -$3.76K | ﹤0.01% | 1761 |
|
|
2023
Q4 | $141K | Buy |
1,465
+164
| +13% | +$14.5K | ﹤0.01% | 1576 |
|
|
2023
Q3 | $115K | Buy |
1,301
+118
| +10% | +$10.5K | ﹤0.01% | 1552 |
|
|
2023
Q2 | $103K | Buy |
1,183
+218
| +23% | +$20.5K | ﹤0.01% | 1551 |
|
|
2023
Q1 | $94K | Buy |
965
+37
| +4% | +$3.84K | ﹤0.01% | 1520 |
|
|
2022
Q4 | $96K | Sell |
928
-2
| -0.2% | -$188 | ﹤0.01% | 1397 |
|
|
2022
Q3 | $79K | Buy |
930
+149
| +19% | +$13.3K | ﹤0.01% | 1442 |
|
|
2022
Q2 | $65K | Buy |
781
+294
| +60% | +$23.4K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $38K | Buy |
487
+396
| +435% | +$33.1K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $8K | Buy |
+91
| New | +$7.51K | ﹤0.01% | 2459 |
|
|
2021
Q2 | $3K | Hold |
33
| – | – | ﹤0.01% | 2499 |
|
|
2021
Q1 | $3K | Hold |
33
| – | – | ﹤0.01% | 2499 |
|
|
2020
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 2499 |
|
|
2020
Q3 | $3K | Hold |
33
| – | – | ﹤0.01% | 2499 |
|
|
2020
Q2 | $3K | Hold |
33
| – | – | ﹤0.01% | 2498 |
|
|
2020
Q1 | $3K | Hold |
33
| – | – | ﹤0.01% | 2498 |
|
|
2019
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 2498 |
|
|
2019
Q3 | $3K | Hold |
33
| – | – | ﹤0.01% | 2498 |
|
|
2019
Q2 | $3K | Hold |
33
| – | – | ﹤0.01% | 2498 |
|
|
2019
Q1 | $3K | Buy |
33
+8
| +32% | +$741 | ﹤0.01% | 2498 |
|
|
2018
Q4 | $2K | Buy |
+25
| New | +$2.38K | ﹤0.01% | 1720 |
|
|
2018
Q1 | – | Sell |
-51
| Closed | -$5K | – | 1416 |
|
|
2017
Q4 | $5K | Hold |
51
| – | – | ﹤0.01% | 1074 |
|
|
2017
Q3 | $5K | Buy |
51
+31
| +155% | +$2.74K | ﹤0.01% | 1067 |
|
|
2017
Q2 | $2K | Buy |
+20
| New | +$1.82K | ﹤0.01% | 993 |
|
|
2017
Q1 | – | Sell |
-20
| Closed | -$2K | – | 1180 |
|
|
2016
Q4 | $2K | Sell |
20
-67
| -77% | -$5.76K | ﹤0.01% | 969 |
|
|
2016
Q3 | $8K | Buy |
+87
| New | +$8.19K | ﹤0.01% | 735 |
|
|
2015
Q4 | – | Sell |
-111
| Closed | -$12K | – | 689 |
|
|
2015
Q3 | $12K | Buy |
+111
| New | +$14.8K | ﹤0.01% | 429 |
|
Other funds holding BMRN
VCM
VPM
Carson Wealth (CWM LLC)'s BMRN Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its BioMarin Pharmaceuticals (BMRN) stake by 84% in Q1 2026, buying an estimated $4.26M and bringing the position to 159,652 shares worth $9.02M. The position accounts for 0.02% of the portfolio, ranked #588.
Carson Wealth (CWM LLC) first reported a position in BMRN in Q3 2015 and has held it in 35 quarters since. 557 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Carson Wealth (CWM LLC) held 159,652 shares of BioMarin Pharmaceuticals worth $9.02M as of Q1 2026.
- Carson Wealth (CWM LLC) bought 73,036 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $4.26M.
- BioMarin Pharmaceuticals made up 0.02% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #588 holding.
- Carson Wealth (CWM LLC) first reported a position in BioMarin Pharmaceuticals in Q3 2015 and has held it in 35 quarters since.
- 557 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.